BioVaxys Technology

BioVaxys is a clinical-stage biopharmaceutical company developing antiviral and anticancer vaccine platforms. The company is evaluating a potential SARS-CoV-2 vaccine based on its gasified viral protein technology and advancing compassionate use trials in the EU to assess its gasified cell vaccine for advanced ovarian cancer.